A Study of BufferGel in Women

NCT00000927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: BufferGel

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)